ES2526316T3 - Procedimientos de identificación de inhibidores del sistema de secreción de tipo III - Google Patents

Procedimientos de identificación de inhibidores del sistema de secreción de tipo III Download PDF

Info

Publication number
ES2526316T3
ES2526316T3 ES11710752.4T ES11710752T ES2526316T3 ES 2526316 T3 ES2526316 T3 ES 2526316T3 ES 11710752 T ES11710752 T ES 11710752T ES 2526316 T3 ES2526316 T3 ES 2526316T3
Authority
ES
Spain
Prior art keywords
component
effector
t3ss
protein
secretion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11710752.4T
Other languages
English (en)
Spanish (es)
Inventor
Thomas C. Marlovits
Julia Radics
Wolfgang Schmied
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Molecular Biotechnology
Original Assignee
Institute of Molecular Biotechnology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Molecular Biotechnology filed Critical Institute of Molecular Biotechnology
Application granted granted Critical
Publication of ES2526316T3 publication Critical patent/ES2526316T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ES11710752.4T 2010-03-23 2011-03-22 Procedimientos de identificación de inhibidores del sistema de secreción de tipo III Active ES2526316T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10157397 2010-03-23
EP10157397 2010-03-23
PCT/EP2011/054379 WO2011117259A1 (en) 2010-03-23 2011-03-22 Methods for identifying inhibitors of the type iii secretion system

Publications (1)

Publication Number Publication Date
ES2526316T3 true ES2526316T3 (es) 2015-01-09

Family

ID=42199515

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11710752.4T Active ES2526316T3 (es) 2010-03-23 2011-03-22 Procedimientos de identificación de inhibidores del sistema de secreción de tipo III

Country Status (7)

Country Link
US (1) US20130130283A1 (enExample)
EP (1) EP2550366B1 (enExample)
JP (1) JP5714692B2 (enExample)
CA (1) CA2793586A1 (enExample)
DK (1) DK2550366T3 (enExample)
ES (1) ES2526316T3 (enExample)
WO (1) WO2011117259A1 (enExample)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5581476A (en) 1993-01-28 1996-12-03 Amgen Inc. Computer-based methods and articles of manufacture for preparing G-CSF analogs
CA2252372C (en) * 1996-04-23 2010-06-29 B. Brett Finlay Pathogenic escherichia coli associated protein
WO1999045136A1 (en) 1998-03-05 1999-09-10 University Of British Columbia Methods for assaying type iii secretion inhibitors
US6248546B1 (en) * 1998-03-09 2001-06-19 Diagnostic Systems Laboratories, Inc. Assay of IGFBP complex
GB0112687D0 (en) * 2001-05-24 2001-07-18 Microbiological Res Authority Pharmaceutical use of secreted bacterial effector proteins
GB0304993D0 (en) * 2003-03-05 2003-04-09 Univ Nottingham Trent Novel screening method
WO2005113791A2 (en) 2004-05-07 2005-12-01 Johnson & Johnson Product Research And Development Methods of identifying modulators of bacterial type iii protein secretion system
EP1795609A1 (en) * 2005-12-06 2007-06-13 Sanofi-Aventis Deutschland GmbH Method for the diagnosis and treatment of cardiovascular diseases
CA2563214A1 (en) * 2006-10-12 2008-04-12 Institut Pasteur Shigella ipad protein and its use as a potential vaccine against shigella infection
WO2009061491A2 (en) 2007-11-07 2009-05-14 University Of Massachusetts Type iii secretion inhibitors and uses thereof
US8716283B2 (en) 2007-11-07 2014-05-06 University Of Massachusetts Type III secretion inhibitors, analogs and uses thereof
WO2009137133A2 (en) 2008-02-14 2009-11-12 University Of Washington 5-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection

Also Published As

Publication number Publication date
WO2011117259A1 (en) 2011-09-29
JP2013522638A (ja) 2013-06-13
EP2550366B1 (en) 2014-11-12
CA2793586A1 (en) 2011-09-29
EP2550366A1 (en) 2013-01-30
US20130130283A1 (en) 2013-05-23
WO2011117259A9 (en) 2011-11-24
JP5714692B2 (ja) 2015-05-07
DK2550366T3 (en) 2014-12-15

Similar Documents

Publication Publication Date Title
Chakraborty et al. Non-canonical activation of OmpR drives acid and osmotic stress responses in single bacterial cells
ES2556996T3 (es) Método para marcar específicamente bacterias vivas
Locke et al. Microbiology and infectious diseases on the move
Yi et al. The CpxR regulates type VI secretion system 2 expression and facilitates the interbacterial competition activity and virulence of avian pathogenic Escherichia coli
US20180016616A1 (en) Methods and compositions for the detection of functional clostridium difficile toxins
CN108780088A (zh) 在伴侣动物中检测炎症标志物和治疗炎性病症的方法
Saitoh et al. Transcription of the ehx enterohemolysin gene is positively regulated by GrlA, a global regulator encoded within the locus of enterocyte effacement in enterohemorrhagic Escherichia coli
US8785402B2 (en) Compositions and assays for treatment and diagnosis of helicobacter pylori infection and conditions
ES2989647T3 (es) Métodos de cribado y aplicaciones terapéuticas basadas en la inhibición de la motilidad bacteriana
Han et al. A novel small RNA regulates Locus of Enterocyte Effacement and site-specific colonization of enterohemorrhagic Escherichia coli O157: H7 in gut
Nakasone et al. Development of a rapid immunochromatographic test to identify enteropathogenic and enterohemorrhagic Escherichia coli by detecting EspB
EP2550366B1 (en) Methods for identifying inhibitors of the type iii secretion system
US8445215B1 (en) Assays and methods for the detection of Crohn's disease
Ball et al. The detection of verocytotoxins in bacterial cultures from human diarrhoeal samples with monoclonal antibody-based ELISAs
WO2014178741A2 (pt) Sonda de ácido péptido nucleico, estojo e método para detectar e / ou quantificar escherichia coli o157 : h7 e respectivas aplicações
Mendes‐Ledesma et al. Production and characterization of rabbit polyclonal sera against Shiga toxins Stx1 and Stx2 for detection of Shiga toxin‐producing Escherichia coli
Zhang et al. The two-component system CpxAR controls biofilm formation by directly regulating the T3SS needle tip protein EseB in Edwardsiella piscicida
Kawagishi et al. Chemotactic behaviors of Vibrio cholerae cells
KR101045666B1 (ko) 결핵의 단계 진단용 마커의 스크리닝 방법 및 발굴된 단백질 항원
Ghosh et al. Entero-adherent Escherichia coli is an important diarrhoeagenic agent in infants aged below 6 months in Calcutta, India
Yamada et al. Detection of antibody to Staphylococcus aureus teichoic acid by enzyme-linked immunosorbent assay
Wen et al. Ultrasensitive detection of Shiga toxin 2 and its variants in Shiga toxin‐producing Escherichia coli strains by a time‐resolved fluorescence immunoassay
Boullier et al. New flow cytometric method to quantify the inhibition of enteropathogenic Escherichia coli adhesion by anti‐adhesin antibodies
US20040137525A1 (en) Detection of salmonella cells by fluorescence polarization
Chart et al. Production of serum antibodies that recognise epitopes located on the R3 region of Escherichia coli core lipopolysaccharides by patients infected with strains of enterohaemorrhagic E. coli